Results 21 to 30 of about 6,025 (196)

ST-Elevation myocardial infarction network: systematization in 205 cases reduced clinical events in the public health care system [PDF]

open access: yes, 2012
BACKGROUND: The major cause of death in the city of São Paulo (SP) is cardiac events. At its periphery, in-hospital mortality in acute myocardial infarction is estimated to range between 15% and 20% due to difficulties inherent in large metropoles ...
Alves, Claudia Maria Rodrigues   +9 more
core   +3 more sources

Sex Differences in Outcomes After Tenecteplase for Minor Stroke: A Subanalysis of the TEMPO‐2 Trial

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background In this subanalysis of the TEMPO‐2 (Tenecteplase Versus Standard of Care for Minor Ischaemic Stroke With Proven Occlusion) trial, a randomized clinical trial comparing tenecteplase and nonthrombolytic control in patients with minor stroke and ...
Amy Y. X. Yu   +13 more
doaj   +1 more source

Contribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolism [PDF]

open access: yes, 2014
Acute pulmonary embolism (PE) can diminish patient quality of life (QoL). The objective was to test whether treatment with tenecteplase has an independent effect on a measurement that reflects QoL in patients with submassive PE.
Courtney, D. Mark   +9 more
core   +1 more source

Tenecteplase in Pulmonary Embolism Patients: A Meta-Analysis and Systematic Review

open access: yesFrontiers in Medicine, 2022
ObjectiveTo assess the efficacy and safety of tenecteplase in patients with pulmonary embolism (PE).MethodsWe completed the literature search on May 31, 2021 using PubMed, EMBASE and the Web of Science.
Zhu Zhang   +43 more
doaj   +1 more source

Tenecteplase versus alteplase for the treatment of acute ischemic stroke: a meta-analysis of randomized controlled trials

open access: yesAnnals of Medicine
Objectives Tenecteplase, a modified variant of alteplase with greater fibrin specificity and longer plasma half-life, may have better efficacy and safety than alteplase in patients with acute ischemic stroke (AIS).
Jian Huang   +4 more
doaj   +1 more source

rLOAD: does sex mediate the effect of acute antiplatelet loading on stroke outcome. [PDF]

open access: yes, 2014
BackgroundBiologic sex can influence response to pharmacologic therapy. The purpose of this proof-of-concept study was to evaluate the medicating effects of estrogen in the efficacy of acute antiplatelet loading therapy on stroke outcome in the rabbit ...
Compton, M Peggy   +4 more
core   +3 more sources

Tenecteplase infusion: The saviour in partially successful thrombolysis of prosthetic heart valve thrombosis

open access: yesIHJ Cardiovascular Case Reports, 2021
A 20-year-old female, with history of mitral valve replacement presented with recent onset breathlessness. Cine fluoroscopy showed restricted leaflet mobility.
Dr A. Shaheer Ahmed   +2 more
doaj   +1 more source

Data science of stroke imaging and enlightenment of the penumbra. [PDF]

open access: yes, 2015
Imaging protocols of acute ischemic stroke continue to hold significant uncertainties regarding patient selection for reperfusion therapy with thrombolysis and mechanical thrombectomy.
Liebeskind, David S   +2 more
core   +2 more sources

Tenecteplase versus alteplase for acute ischaemic stroke in the elderly patients: a post hoc analysis of the TRACE-2 trial

open access: yesStroke and Vascular Neurology
Background The benefit–risk profile of tenecteplase in the elderly patients with acute ischaemic stroke (AIS) is uncertain. We sought to investigate the efficacy and safety of 0.25 mg/kg tenecteplase compared with alteplase for AIS patients aged ≥80 ...
Bruce C V Campbell   +13 more
doaj   +1 more source

The safety of enoxaparine use in elderly with acute myocardial infarction [PDF]

open access: yes, 2007
Background/Aim. Enoxaparin (ENOX), the lowmolecular- weight heparin, used in acute myocardial infarction (AMI) could lead to hemorrhage. The aim of this study was to determine whether bleeding was more often in AMI patients older than 65 or 75 years who ...
Despotović Nebojša   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy